Login to Your Account



'Dawn of a New Era'

Geron Soars as First ESC Trial Clears FDA Hurdle

By Jennifer Boggs


Monday, January 26, 2009
Embryonic stem cells, which have been hailed as a potential revolutionary development in the field of regenerative medicine since the creation of the first cell line more than 10 years ago and also have generated a hailstorm of controversy in political and religious arenas, finally have a chance to prove their mettle in patients. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription